Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

352 ARTÍCULOS , VIENDO DEL 166 AL 180

Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease

Goswami S, Hartz SM, Oliver A, Jackson S, Ogungbenle T, Evans A, Linnenbringer E, Moulder KL, Morris JC, Mozersky J.

JAMA Netw Open. 2025 May 1;8(5):e252919. doi: 10.1001/jamanetworkopen.2025.2919.

SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studies

Kuhn E, Klinger HM, Amariglio RE, Wagner M, Jessen F, Düzel E, Heneka MT, Chételat G, Rentz DM, Sperling RA, Ebenau JL, Butterbrod E, Van Der Flier WM, Sikkes SAM, Teunnissen CE, Van Harten AC, Van De Giessen EM, Rami L, Tort A, Sánchez Benavides G, Gifford KA, Van Hulle C, Buckley RF; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle flagship study of ageing, A4 Study Team; DELCODE Study; Harvard Aging Brain Study.

Alzheimers Dement. 2025 May;21(5):e14307. doi: 10.1002/alz.14307. Epub 2025 Feb 22.

Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer's Disease: A Cross-sectional Study

Luca A, Politis A, Luca M, Ferri R, Grasso M, Drago F, Nicoletti A, Serretti A.

Curr Alzheimer Res. 2025;22(5):396-402. doi: 10.2174/0115672050384313250612045355.

Diagnosis of Alzheimer's disease: Recommendations from the French Federation of Memory Clinics

Dumurgier J, Défontaines B, Gallouj K, Garcin B, Garnier-Crussard A, Lagarde J, Pauly JM, Rollin Sillaire A, Rouch-Leroyer I, Sarazin M, Verny M, Wallon D.

Rev Neurol (Paris). 2025 Dec;181(10):1021-1029. doi: 10.1016/j.neurol.2025.09.004. Epub 2025 Sep 30.

A Comprehensive Review on Deep Learning Techniques in Alzheimer's Disease Diagnosis

Mahavar A, Patel A, Patel A.

Curr Top Med Chem. 2025;25(4):335-349. doi: 10.2174/0115680266310776240524061252.

Quantum dots in neurotheranostics for the treatment of Alzheimer's disease

Sharma T, Bashir B, Sharma P, Andotra N, Singh SK, Singh TG, Vishwas S.

Ageing Res Rev. 2025 Dec;112:102876. doi: 10.1016/j.arr.2025.102876. Epub 2025 Aug 20.

Paving the way for Alzheimer's disease blood-based biomarkers in primary care

Erickson CM, Largent EA, O'Brien KS.

Alzheimers Dement. 2025 Jan;21(1):e14203. doi: 10.1002/alz.14203. Epub 2024 Dec 30.

Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer's disease

Ketron GL, Grun F, Grill JD, Feldman HH, Rissman RA, Brewer GJ.

Alzheimers Res Ther. 2025 Mar 11;17(1):59. doi: 10.1186/s13195-025-01693-y.

P-tau217 as a Biomarker in Alzheimer's Disease: Applications in Latin American Populations

Varela-Vidales CA, Martínez-Hernández A, Hernández-Castellanos E, Delgado-Lara DLC.

Int J Mol Sci. 2025 Jul 10;26(14):6633. doi: 10.3390/ijms26146633.

UCH-L1 in Alzheimer's Disease: A Crucial Player in Dementia-Associated Mechanisms

Porchietto E, Morello G, Cicilese G, Rainero I, Rubino E, Tamagno E, Boschi S, Guglielmotto M.

Int J Mol Sci. 2025 Sep 16;26(18):9012. doi: 10.3390/ijms26189012.

Early detection of Alzheimer's disease using small RNAs. Results from the EPAD cohort

Sikosek T, Heuvelman M, Mika J, Kahraman M, Jehn J, Frank M, Daniel-Moreno A, Ceiler J, Skottke J, Sanchez-Delgado M, Neubert P, Rudolf C, Tikk K, Horos R, Cummings JL, Butchart J, Ritchie C, Manson J, Steinkraus BR; EPAD consortium.

J Prev Alzheimers Dis. 2025 Sep;12(8):100257. doi: 10.1016/j.tjpad.2025.100257. Epub 2025 Jun 28.

The Alzheimer's Disease Continuum - A New Diagnostic Approach

Drake J, Warren S, Wu CK.

R I Med J (2013). 2025 May 1;108(5):8-12.

Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study

Kemna RE, Kueck PJ, Blankenship A, John CS, Johnson CN, Green ZD, Mayfield H, Yoksh L, Johnson L, Thyfault JP, Mahnken JD, Miller BF, Morris JK.

Alzheimers Dement. 2025 Dec;21(12):e70984. doi: 10.1002/alz.70984.

Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice

Hazan J, Liu KY, Isaacs JD, Howard R.

Alzheimers Dement. 2025 Mar;21(3):e70113. doi: 10.1002/alz.70113.

Predicting cognitive decline in Alzheimer's disease: A real-life proof-of-principle study on multimodal assessment

Motolese F, Norata D, Iaccarino G, Sapio E, Lodico S, Di Giesi ML, Cruciani A, Rossi M, Pilato F, Di Lazzaro V, Capone F.

J Alzheimers Dis. 2025 Nov;108(1):378-386. doi: 10.1177/13872877251376676. Epub 2025 Sep 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias